🇺🇸 FDA
Patent

US 9260446

Synthetic methods for spiro-oxindole compounds

granted A61PA61P25/00A61P25/04

Quick answer

US patent 9260446 (Synthetic methods for spiro-oxindole compounds) held by Xenon Pharmaceuticals Inc. expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P25/00, A61P25/04